Publication details
Efalizumab – východisko v léčbě těžké psoriázy
| Title in English | Efalizumab as a successful treatment for severe psoriasis |
|---|---|
| Authors | |
| Year of publication | 2008 |
| Type | Paper in proceedings |
| Conference | Česko-slovenská dermatologie |
| MU Faculty or unit | |
| Citation | |
| Field | Dermatovenerology |
| Keywords | psoriasis; efalizumab; quality of life |
| Description | A successful treatment of a chronic severe psoriasis with efalizumab is described. Efalizumab is a humanized monoclonal antibody against CD11a subunit of LFA-1 molecule which is a co-stimulative signal necessary for an activation of T-lymfocytes. |